Skip to main content
Clinical Trials/ACTRN12622000360718
ACTRN12622000360718
Not yet recruiting
未知

The effect of nutrition supplementation before and after revascularisation procedure in people with peripheral arterial disease compare to usual care: The Peri-operative nutrition in Peripheral Arterial Disease (PPAD) trial.

Abbott Medical Australia Pty Ltd0 sites264 target enrollmentMarch 1, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Peripheral arterial disease
Sponsor
Abbott Medical Australia Pty Ltd
Enrollment
264
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 1, 2022
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Abbott Medical Australia Pty Ltd

Eligibility Criteria

Inclusion Criteria

  • Inpatients and outpatients at Flinders Medical Centre who are scheduled to undergo open or endovascular revascularisation for PAD.

Exclusion Criteria

  • Patients will be excluded if they are: 1\) \<18 years old; 2\) have been diagnosed with a terminal illness; 3\) are unable to communicate effectively to provide informed consent such as those with cognitive impairment; 4\) have a diagnosis of galactosemia (a contra\-indication to immuno\-nutrition supplement) or 5\) have a fluid restriction.

Outcomes

Primary Outcomes

Not specified

Similar Trials